SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15371854
Source:
http://linkedlifedata.com/resource/pubmed/id/15371854
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0033572
,
umls-concept:C0036397
,
umls-concept:C0038148
,
umls-concept:C0087111
,
umls-concept:C0243077
,
umls-concept:C1704272
,
umls-concept:C2252854
,
umls-concept:C2699007
pubmed:issue
4 Pt 1
pubmed:dateCreated
2004-9-16
pubmed:abstractText
We reviewed the physiological and pathogenic role of dihydrotestosterone (DHT), evidence for the beneficial effects of decreasing DHT through 5alpha-reductase inhibition and the effects of altering the androgen balance with these agents.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0376374
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/5-alpha Reductase Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Azasteroids
,
http://linkedlifedata.com/resource/pubmed/chemical/Dihydrotestosterone
,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Finasteride
,
http://linkedlifedata.com/resource/pubmed/chemical/dutasteride
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0022-5347
pubmed:author
pubmed-author:AndrioleGeraldG
,
pubmed-author:BruchovskyNicholasN
,
pubmed-author:ChungLeland W KLW
,
pubmed-author:MatsumotoAlvin MAM
,
pubmed-author:RittmasterRogerR
,
pubmed-author:RoehrbornClausC
,
pubmed-author:RussellDavidD
,
pubmed-author:TindallDonaldD
pubmed:issnType
Print
pubmed:volume
172
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1399-403
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:15371854-5-alpha Reductase Inhibitors
,
pubmed-meshheading:15371854-Azasteroids
,
pubmed-meshheading:15371854-Clinical Trials as Topic
,
pubmed-meshheading:15371854-Dihydrotestosterone
,
pubmed-meshheading:15371854-Enzyme Inhibitors
,
pubmed-meshheading:15371854-Finasteride
,
pubmed-meshheading:15371854-Humans
,
pubmed-meshheading:15371854-Male
,
pubmed-meshheading:15371854-Prostatic Hyperplasia
,
pubmed-meshheading:15371854-Treatment Outcome
,
pubmed-meshheading:15371854-Urinary Bladder Neck Obstruction
pubmed:year
2004
pubmed:articleTitle
Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia.
pubmed:affiliation
Division of Urological Surgery, Washington University in St. Louis, St. Louis, Missouri 63110, USA.
pubmed:publicationType
Journal Article
,
Review